However, the literatures focused on DNA methylation of nfe2l2 in the treatment of DM-related cardiac and vascular diseases are limited, and the mechanisms by which miRNAs exert their direct effects on NRF2 have been largely lacking. The gene discussed is NFE2L2; the disease is diabetes mellitus.